Graphs Tables for Skin Cancer

http://www.aseanface.com/music/social_music_home.php

http://www.aseanface.com/social_classified.php

http://www.aseanface.com/social_display_article.php

http://www.aseanface.com/about_us.php

http://www.aseanface.com/contact_us.php

http://www.aseanface.com/privacy_policy.php

http://www.aseanface.com/aff_banner_code.php

http://www.aseanface.com/terms_service.php

http://www.aseanface.com/social_member_home.php

Fwd: Interaction between warfarin and tamoxifen: A case report.

---------- Forwarded message ----------
From: HubMed - breast cancer <rssfwd@rssfwd.com>
Date: Wed, Jul 9, 2008 at 5:03 PM
Subject: Interaction between warfarin and tamoxifen: A case report.
To: mesothelioma77@gmail.com

[1]Kathmandu Univ Med J (KUMJ). 2007 Jan-Mar; 5(1): 105-7
Mishra D, Paudel R, Kishore PV, Palaian S, Bista D, Misra P

Warfarin is a commonly used anticoagulant with documented reports of drug interactions. Tamoxifen is used in the adjuvant hormonal treatment of women with oestrogen-receptor- positive breast cancer. Warfarin and tamoxifen are known to interact with each other with a resultant increase in the bleeding tendency. These reports are mainly from the white population. We report a case of drug interaction between warfarin and tamoxifen with an acute onset. This report suggests that when these drugs are co administered, careful monitoring of the coagulation profile is needed. Key words: Drug interaction, Tamoxifen, Warfarin.

___
Source: http://www.hubmed.org/display.cgi?uids=18603996
--
~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

AseanFace URLs

http://www.aseanface.com/music/social_music_home.php

http://www.aseanface.com/social_classified.php

http://www.aseanface.com/social_display_article.php

http://www.aseanface.com/about_us.php

http://www.aseanface.com/contact_us.php

http://www.aseanface.com/privacy_policy.php

http://www.aseanface.com/aff_banner_code.php

http://www.aseanface.com/terms_service.php

http://www.aseanface.com/social_member_home.php

Fwd: The ShcA adaptor protein is a critical regulator of breast cancer progression.

---------- Forwarded message ----------
From: HubMed - breast cancer <rssfwd@rssfwd.com>
Date: Wed, Jul 9, 2008 at 5:03 PM
Subject: The ShcA adaptor protein is a critical regulator of breast cancer progression.
To: mesothelioma77@gmail.com

[1]Cell Cycle. 2008 Apr 24; 7(13):
Ursini-Siegel J, Muller WJ

Breast cancer affects 1 in 8 North American women throughout their lifetime and is the second leading cause of cancer-related deaths. Breast cancer is a heterogeneous disease whose progression from hyperplasia to ductal carcinoma in situ and invasive carcinoma is regulated by the aberrant expression of multiple mediators; including growth factors, cytokines, chemokines and proteases that are produced both by the mammary tumor itself and the adjacent reactive stroma. These signals promote tumor cell proliferation, survival, establishment of a tumor vasculature, invasion and ultimately metastasis to secondary organs. Moreover, the ability of the tumor to create a state of local immune suppression allows tumor cells to evade clearance by the immune system. ShcA is an adaptor protein that relays extracellular signals downstream of receptor tyrosine kinases. Clinical studies suggest that activation of the ShcA signaling pathway is associated with poor patient prognosis. Moreover, recent studies with transgenic mouse models have clearly demonstrated the importance of tumor autonomous ShcA signaling, as well as signaling in cells comprising the tumor microenvironment, for the regulation of these biological processes, which contribute to breast cancer development and metastasis.

___
Source: http://www.hubmed.org/display.cgi?uids=18604176
--
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

AseanFace URLs

http://www.aseanface.com/music/social_music_home.php

http://www.aseanface.com/social_classified.php

http://www.aseanface.com/social_display_article.php

http://www.aseanface.com/about_us.php

http://www.aseanface.com/contact_us.php

http://www.aseanface.com/privacy_policy.php

http://www.aseanface.com/aff_banner_code.php

http://www.aseanface.com/terms_service.php

http://www.aseanface.com/social_member_home.php

Fwd: Periductal stromal sarcoma of breast with lipoblast-like cells: A case report with review of literature.

---------- Forwarded message ----------
From: HubMed - breast cancer <rssfwd@rssfwd.com>
Date: Wed, Jul 9, 2008 at 5:03 PM
Subject: Periductal stromal sarcoma of breast with lipoblast-like cells: A case report with review of literature.
To: mesothelioma77@gmail.com

[1]Indian J Pathol Microbiol. 2008 Apr; 51(2): 252-4
Rao AC, Geetha V, Khurana A

The specialized mesenchyme of the breast is the seat of neoplasms with distinct morphology, though with considerable overlap due to the ever increasing number of variants. This article seeks to describe the morphologic features of one such rare neoplasm. A 35-year-old female patient presented with a breast lump that was subsequently excised. Morphological assessment and immunohistochemistry were performed and a diagnosis of periductal stromal sarcoma with lipoblast-like cells (pseudolipoblasts), was made. Being an unusual finding in a rare entity of intermediate grade, it has to be considered, before rendering a diagnosis of a malignant, higher-grade neoplasm.

___
Source: http://www.hubmed.org/display.cgi?uids=18603698
--
~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

AseanFace URLs

http://www.aseanface.com/music/social_music_home.php